Seattle Genetics

SGEN

SGEN
Seattle Genetics Stock Quote
$111.70 $3.03 2.8%
BATS BZX Real Time Price as of January 22, 2020, 4:30 p.m. EST View Interactive SGEN Charts

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

News & Analysis: Seattle Genetics

The Fool has written over 200 articles on Seattle Genetics.

All

Market Moves

Earnings










4 Stocks Battling Breast Cancer

With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.


Interactive Chart